The largest database of trusted experimental protocols

8 protocols using c 12974

1

Comparative Analysis of hMSC Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two hMSC cell lines obtained from the bone marrow of healthy donors, provided by two different commercial suppliers – PT-2501 from a 21-year-old female and a 22-year-old female (Lonza Group Ltd, Basel, Switzerland), and C-12974 from a 64-year-old male (PromoCell GmbH, Heidelberg, Germany) – were used in this study. Because these cells are commercially available, no patient consent or approval from Ethics Committee was needed.
Cells were cultured at 37°C and 8% carbon dioxide with the media recommended by the manufacturer. The media were changed every other day and the cells were split enzymatically with Trypsin: 1× phosphate-buffered saline (Ref. 14190–185; Gibco Life Technologies) and Tryple Express (Ref. 12604–013; Gibco-Life Technologies) for PT-2501 cells, and the Trypsin kit (PromoCell GmbH) for C-12974 cells. Cultures were trypsinized when the cells were approximately 90% confluent.
+ Open protocol
+ Expand
2

Cytocompatibility and Osteoinductive Potential of Biomaterials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human osteoblast-like cells (HOS TE85) from European Collection of Authenticated Cell Cultures (ECACC) were used for cytocompatibility screening. Cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM; 6046 SIGMA) containing 10% foetal calf serum (FCS) (Sigma F7524, non-USA origin), 5% HEPES, 1% minimal essential medium (MEM) (Sigma), 20 mM L-glutamines, and 1.5% ascorbate powder. Primary human bone marrow mesenchymal stem cells (hBMSC’s) (PromoCell C-12974) were used for investigation of osteoinductive potential of the scaffolds and were cultured in growth medium (PromoCell C-28009) from the same company. Cells were grown in a cell culture incubator with 5% CO2 level and 95% humidity at 37 °C. Test samples were sterilised by gamma irradiation (1.2 Mrad). Dynex Opsys MR™ colorimetric absorbance reader (570/620 nm) and Revelation software were used to quantify the optical data in MTT, protein and proliferation assays.
+ Open protocol
+ Expand
3

Characterization of Immortalized and Primary MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
UE7T-13 (immortalized human BM-MSCs; JCRB1154), and UCB408E7-TERT34 (immortalized human umbilical cord blood-derived MSCs [UCB-MSCs]; JCRB1546) were purchased from JCRB Cell Bank. UE7T-13 and UCB408E7-TERT34 were cultured in low glucose-Dulbecco's Modified Eagle's Medium (SIGMA-Aldrich, St. Louis, MO) supplemented with 10% FBS (fetal bovine serum), 100 U/mL penicillin, and 100 μg/mL streptomycin. HUVECs (Lonza, Basel, Switzerland) were cultured in EGM2 medium (Lonza). Human hepatic sinusoidal endothelial cells (P10652; Innoprot, Bizkaia, Spain) (hLSEC#1) were cultured in endothelial cell medium (P60104; Innoprot). The primary human bone marrow-derived MSCs used in this study were purchased from the PromoCell GmbH (Heidelberg, Germany). Primary human bone marrow-derived MSCs (C-12974; PromoCell) were cultured in Mesenchymal Stem Cell Growth Medium 2 (C-28009; PromoCell). The characteristics as MSCs including adipogenesis, chondrogenesis, and osteogenesis potencies of the primary human bone marrow-derived MSCs were checked by the supplier.
+ Open protocol
+ Expand
4

Mesenchymal Stromal Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The current study used human bone marrow-derived mesenchymal stromal cells (hBM-MSCs) as in vitro models to analyze MSC differentiation into adipocytes and osteoblast. Cells were purchased from PromoCell (C-12974, Heidelberg, Germany). For the experiments, cells at passage numbers between 3 and 6 were cultured in 6-well plates (1 × 106 cells/well) unless otherwise noted. Prior to differentiation, cells were grown to confluency during which they were fed mesenchymal stem cell growth medium (C-28009, PromoCell). Following confluency, hBM-MSCs were induced to differentiate into adipocytes or osteoblasts by swapping the culture medium with mesenchymal stem cell adipogenic differentiation medium 2 (C-28016, PromoCell) or mesenchymal stem cell osteogenic differentiation medium (C-28013, PromoCell), respectively. Cells introduced to differentiation media were incubated for 10 days, swapping the differentiation medium with fresh media every third day. Treatment with M3G was carried out along with initial differentiation inducement only. Incubation of hBM-MSCs before and during the differentiation was in controlled incubators set to 37 °C temperature and 5% CO2 level.
+ Open protocol
+ Expand
5

Osteoblast Differentiation with PFF-A

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine osteoblast-like MC3T3-E1 cells obtained from ATCC (CRL-2593) and huBM-MSCs obtained from PromoCell (C-12974) were cultured in 6-well plates unless otherwise noted. MC3T3-E1 cells were fed with α-Modified minimal essential medium (αMEM) containing 10% fetal bovine serum (heat-inactivated, v/v), 1 mM sodium pyruvate, 100 units/L penicillin and 100 mg/L streptomycin in an atmosphere of 5% CO2 at 37 °C. Following the confluence, osteoblast differentiation was induced with a differentiation cocktail of 50 μg/mL ascorbic acid and 10 mM β-glycerophosphate in cell culture medium. PFF-A was introduced to the cells with differentiation medium and included in every medium change (every second day).
huBM-MSCs were fed with mesenchymal stem cell growth medium (C-28009, PromoCell) and incubated in an atmosphere of 5% CO2 at 37 °C. Following 100% confluence cells were induced by MSC osteogenic differentiation medium (C-28013, PromoCell) and incubated until the time of analysis. PFF-A was introduced with differentiation medium and included in all medium changes (every third day).
+ Open protocol
+ Expand
6

Osteogenic Differentiation of MSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cultures of MSPCs were obtained from PromoCell (C-12974, Heidelberg, Germany). Cells were characterized by the vendor according to criteria proposed by the International Society for Cellular Therapy (Dominici et al., 2006) . Lot 402Z027 (47, male, Caucasian) was used in RNA-seq study. Lot 429Z013.1 (56, male, Caucasian) was used in siRNA knockdown study. MSPCs were initially cultured in recommended growth media (PromoCell, C28009) and differentiated in MSPC osteogenic differentiation medium (PromoCell, C-28013) on plates coated with human fibronectin (PromoCell, C-43060). Media was changed every two or three days. Samples for osteogenic differentiation RNA-seq data were obtained at day 0, 2, 4, 6, 8, and 12; and daily samples from day 0 to 7 for siRNA knockdown.
+ Open protocol
+ Expand
7

Culturing Human Bone-Marrow Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bone-marrow mesenchymal stem cells (bMSC) were purchased from PromoCell (C-12974) and cultivated in low glucose Dulbecco’s modified Eagle medium (DMEM; Sigma-Aldrich, Milan, Italy) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, Milan, Italy) and 1% antibiotics at 37 °C, 5% CO2 atmosphere. Cells were cultivated until 80–90% confluence, detached by a trypsin EDTA solution (0.25% in PBS), harvested and used for experiments.
+ Open protocol
+ Expand
8

Bone Healing Potential of Composite Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells representative for the bone healing process after composite implantation were tested. Accordingly, human mesenchymal stem cells (hMSCs), human primary osteoblasts progenitors, and human endothelial cells were directly cultivated in contact with control 100% BG and test composites.
Human mesenchymal stem cells (hMSC) were purchased from Merck (C-12974 from PromoCell GmbH, Heidelberg, Germany, distributed by Merck, Milan, Italy) and cultivated in low-glucose Dulbecco’s modified Eagle Medium (DMEM, Merck) supplemented with 15% fetal bovine serum (FBS, Merck) and 1% antibiotics (penicillin/streptomycin, Merck) at 37 °C, 5% CO2 atmosphere. Human primary osteoblasts progenitors (hFOB 1.19 CRL-11372) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultivated in MEM/F12 mix medium (50:50, from Sigma, Darmstadt, Germany) 10% fetal bovine serum (FBS, from Sigma) 1% antibiotics, and 3 mg/mL neomycin (G418 salt, Sigma) at 34 °C, 5% CO2 atmosphere. Human endothelial cells (EA.hy926, CRL-2922) were purchased from ATCC and cultivated in high-glucose Dulbecco’s modified Eagle Medium (DMEM, Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1% antibiotics (penicillin/streptomycin) at 37 °C, 5% CO2 atmosphere. Cells were cultivated until 80–90% confluence, detached by trypsin-EDTA solution, harvested, and used for experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!